Osteotech Inc. (OSTE) has postponed its annual shareholder meeting after the company, embroiled in a proxy battle, struck a deal Tuesday to be bought by Medtronic Inc. (MDT) for about $123 million.

Osteotch, citing its freshly signed merger agreement in which Medtronic has agreed to pay $6.50 for each of its shares, said Wednesday it has postponed the meeting, which was scheduled for this coming Monday. The company, which provides human bone and bone connective tissue used in transplants, said it would schedule a special stockholder meeting "as soon as possible" to approve the merger pact.

If the acquisition isn't completed, the company will reschedule its annual meeting. The deal is subject to Osteotech shareholder and other regulatory approvals.

Osteotech earlier this month said it hired Deutsche Bank AG (DB) to explore potential alternatives for the company in the wake of a proxy fight with dissident investors. The group, which owns 23% of Osteotech's stock, was running a four-person slate of candidates for election to Osteotech's board, citing the company's beaten-down stock and erosion of its results.

A member of the dissident group said on Tuesday that they were "currently reviewing the transaction and will reserve comment until an appropriate time."

Shares of Osteotech closed at $6.44 on Tuesday and were inactive premarket. The stock has more than doubled so far this year.

-By Nathan Becker, Dow Jones Newswires; 212-416-2855; nathan.becker@dowjones.com

Order free Annual Report for Medtronic Inc.

Visit http://djnewswires.ar.wilink.com/?link=MDT or call 1-888-301-0513

 
 
Grafico Azioni Osteotech Com (MM) (NASDAQ:OSTE)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Osteotech Com (MM)
Grafico Azioni Osteotech Com (MM) (NASDAQ:OSTE)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Osteotech Com (MM)